siRNA silencing of gene expression in trabecular meshwork: RhoA siRNA reduces IOP in mice

Current Molecular Medicine

Volumn 12, Issue 8, 2012, Pages 1015-1027

  Liu, Q ^a   Wu, K ^a   Qiu, X ^a   Yang, Y ^a   Lin, X ^a   Yu, M ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

IOP; Mice; RhoA; Silencing; siRNA; Trabecular meshwork

Indexed keywords

EOSIN; HEMATOXYLIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DOWN REGULATION; FEMALE; FLUORESCENCE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLAUCOMA; IMMUNOFLUORESCENCE; INTRAOCULAR PRESSURE; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY; TRABECULAR MESHWORK;

ANIMALS; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INJECTIONS, INTRAOCULAR; INTRAOCULAR PRESSURE; MALE; MICE; MICE, INBRED BALB C; NIH 3T3 CELLS; OCULAR HYPERTENSION; RHO GTP-BINDING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRABECULAR MESHWORK;

ANIMALIA; MUS;

EID: 84866528532     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412802480907     Document Type: Article

References (58)

1. Tan JC, Peters DM, Kaufman PL. Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol 2006; 17: 168-74.
2. Lutjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res 1999; 18: 91-119.
3. Francis BA, Alvarado J. The cellular basis of aqueous outflow regulation. Curr Opin Ophthalmol 1997; 8: 19-27.
4. Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci 2000; 41: 619-623.
5. Polansky JR, Wood IS, Maglio MT, Alvarado JA. Trabecular meshwork cell culture in glaucoma research: evaluation of biological activity and structural properties of human trabecular cells in vitro. Ophthalmology 1984; 91: 580-595.
6. Yue BY. The extracellular matrix and its modulation in the trabecular meshwork. Surv Ophthalmol 1996; 40: 379-90.
7. Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 2005; 24: 612-37.
8. Lutjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp Eye Res 2005; 81: 1-4.
9. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004; 363: 1711-20.
10. Stieger K, Cronin T, Bennett J, Rolling F. Adeno-associated virus mediated gene therapy for retinal degenerative diseases. Methods Mol Biol 2011; 807: 179-218.
11. Campochiaro PA. Gene transfer for ocular neovascularization and macular edema. Gene Ther 2012; 19: 121-6.
12. Ritter T, Yang J, Dannowski H, et al. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. Transpl Immunol 2007; 18: 101-7.
13. Li H, Ao X, Jia J, et al. Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells. Mol Vis 2011; 17: 3314-25.
14. Wilson AM, Di Polo A. Gene therapy for retinal ganglion cell neuroprotection in glaucoma. Gene Ther 2012; 19: 127-36.
15. Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003; 9: 1291-300.
16. Zhou J, Rossi JJ. Current progress in the development of RNAi-based therapeutics for HIV-1. Gene Ther 2011; 18: 1134-8.
17. Li F, Mahato RI. RNA interference for improving the outcome of islet transplantation. Adv Drug Deliv Rev 2011; 63: 47-68.
18. Kim B, Tang Q, Biswas PS, et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 2004; 165: 2177-85.
19. Martin-Gil A, de Lara MJ, Crooke A, et al. Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits. Br J Pharmacol 2012; 165: 1163-72.
20. Loewen N, Fautsch MP, Teo WL, et al. Long-term, targeted genetic modification of the aqueous humor outflow tract coupled with noninvasive imaging of gene expression in vivo. Invest Ophthalmol Vis Sci 2004; 45: 3091-8.
21. Buie LK, Rasmussen CA, Porterfield EC, et al. Selfcomplementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. Invest Ophthalmol Vis Sci 2010; 51: 236-48.
22. Streilein J. Immune Response and the Eye. Boston: Karger 1999.
23. Honjo M, Tanihara H, Inatani M, et al. Effects of rhoassociated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 2001; 42: 137-144.
24. Vittitow JL, Garg R, Rowlette LL, et al. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis 2002; 8: 32-44.
25. Varon C, Tatin F, Moreau V, et al. Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol 2006; 26: 3582-94.
26. Petermann P, Haase I, Knebel-Morsdorf D. Impact of Rac1 and Cdc42 signaling during early herpes simplex virus type 1 infection of keratinocytes. J Virol 2009; 83: 9759-72.
27. Bhattacharyya R, Banerjee J, Khalili K, Wedegaertner PB. Differences in Galpha12-and Galpha13-mediated plasma membrane recruitment of p115-RhoGEF. Cell Signal 2009; 21: 996-1006.
28. Duan F, Ni S, Nie Y, et al. SiRNA Targeting for ICP4 Inhibits HSV-1 Replication in Retinal Pigment Epithelial Cells. Clin Experiment Ophthalmol 2011; 40: 195-204.
29. Zhuo YH, Huang YL, Wei YT, et al. Glucocorticoids upregulate transepithelial electrical resistance and expression of tight junction-related protein in human trabecular meshwork cells. Chin Med J (Engl) 2005; 118: 1742-5.
30. Chen M, Liu B, Gao Q, et al. Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2011; 52: 7027-37.
31. Zhang X, Ognibene CM, Clark AF, Yorio T. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta. Exp Eye Res 2007; 84: 275-84.
32. Wentz-Hunter K, Kubota R, Shen X, Yue BY. Extracellular myocilin affects activity of human trabecular meshwork cells. J Cell Physiol 2004; 200: 45-52.
33. Hans E, Matthew W, Brent C. Anterior vs Posterior intraocular Melanoma. Arch Ophthalmol 1996; 114: 1116-20.
34. Whitlock NA, McKnight B, Corcoran KN, et al. Increased intraocular pressure in mice treated with dexamethasone. Invest Ophthalmol Vis Sci 2010; 51: 6496-503.
35. Reitsamer HA, Kiel JW, Harrison JM, et al. Tonopen measurement of intraocular pressure in mice. Exp Eye Res 2004; 78: 799-804.
36. Pang IH, Wang WH, Millar JC, Clark AF. Measurement of mouse intraocular pressure with the Tono-Pen. Exp Eye Res 2005; 81: 359-60.
37. Shinzato M, Yamashiro Y, Miyara N, et al. Proteomic analysis of the trabecular meshwork of rats in a steroidinduced ocular hypertension model: downregulation of type I collagen C-propeptides. Ophthalmic Res 2007; 39: 330-37.
38. Miyara N, Shinzato M, Yamashiro Y, et al. Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress. Jpn J Ophthalmol 2008; 52: 84-90.
39. Ma X, Wu MX, Zhang YL, et al. Difference of gene expression between the central and the peripheral epithelia of the bovine lens. Chin Med J (Engl) 2009; 122: 1072-80.
40. Yu M, Sun J, Peng W, et al. Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro. Mol Vis 2010; 16: 213-23.
41. Zhong H, Sun G, Lin X, et al. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci 2011; 52: 3136-42.
42. Challa P, Luna C, Liton PB, et al. Lentiviral mediated gene delivery to the anterior chamber of rodent eyes. Mol Vis 2005; 11: 425-30.
43. Bainbridge JW, Stephens C, Parsley K, et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther 2001; 8: 1665-8.
44. Scanlon KJ. An overview of the tenth international conference on cancer gene therapy. Cancer Gene Ther 2001; 8: 906-8.
45. Khare R, Chen CY, Weaver EA, Barry MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 2011; 11: 241-58.
46. Gregory SM, Nazir SA, Metcalf JP. Implications of the innate immune response to adenovirus and adenoviral vectors. Future Virol 2011; 6: 357-74.
47. Zamore PD. RNA interference: big applause for silencing in Stockholm. Cell 2006; 127: 1083-86.
48. Hong H, Zhang Y, Cai W. In vivo imaging of RNA interference. J Nucl Med 2010; 51: 169-72.
49. Comes N, Borras T. Functional delivery of synthetic naked siRNA to the human trabecular meshwork in perfused organ cultures. Mol Vis 2007; 13: 1363-74.
50. Masuda I, Matsuo T, Yasuda T, Matsuo N. Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 1996; 37: 1914-20.
51. Hu Y, Huang Q, Jiang F, Chen H. The expression of the plasmid DNA encoding TGF-beta 1 in endothelium after injection into the anterior chamber. J Huazhong Univ Sci Technolog Med Sci 2002; 22: 320-3.
52. Abul-Hassan K, Walmsley R, Boulton M. Optimization of nonviral gene transfer to human primary retinal pigment epithelial cells. Curr Eye Res 2000; 20: 361-6.
53. Dannowski H, Bednarz J, Reszka R, et al. Lipid-mediated gene transfer of acidic fibroblast growth factor into human corneal endothelial cells. Exp Eye Res 2005; 80: 93-101.
54. Shafaa MW, Sabra NM, Fouad RA. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits. Biopharm Drug Dispos 2011; 32: 507-17.
55. Garcia-Arumi J, Pascual R, Fonseca MJ, et al. Pharmacokinetics and retinal toxicity of intravitreal liposomeencapsulated 5-fluorouridine. Ophthalmologica 1997; 211: 344-50.
56. Peng D, Yu K, Zeng S, et al. An experimental study on homoharringtonine liposome and glaucoma filtration surgery. Yan Ke Xue Bao 1999; 15: 51-4, 50.
57. Zhang M, Maddala R, Rao PV. Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork. Am J Physiol Cell Physiol 2008; 295: C1057-70.
58. Akaishi T, Odani-Kawabata N, Ishida N, Nakamura M. Ocular hypotensive effects of anti-glaucoma agents in mice. J Ocul Pharmacol Ther 2009; 25: 401-8.